Background/Aims: Treatment of renal problems during natural catastrophes is highly complicated both for medical and logistic reasons. The therapeutic interventions applied to and the outcome of 639 victims with acute renal problems during the catastrophic Marmara earthquake have been the subject of this study. Methods: Questionnaires regarding information about 63 clinical and laboratory variables were sent to 35 reference hospitals that treated the victims. Information considering therapeutic interventions and outcome obtained through these questionnaires was submitted to analysis. Results: At least one form of renal replacement therapy was administered to 477 (74.6%) of the 639 victims. Of these, 437, 11, and 4 were treated solely by intermittent hemodialysis, continuous renal replacement therapy, and peritoneal dialysis, respectively; 25 victims needed more than one dialysis modality. In total, 5,137 hemodialysis sessions were performed. Also, 2,981, 2,837 and 2,594 units of blood, fresh frozen plasma, and human albumin were administered, respectively. Transfusion of these products was usually associated with higher rates of dialysis needs and mortality. Ninety-seven patients (15.2%) died. The mortality rate of dialyzed victims was higher as compared to nondialyzed ones (17.2 vs. 9.3%, p = 0.015). Conclusions: Massive amounts of dialysis treatment as well as blood and blood product transfusions can be necessary in the treatment of catastrophic earthquake victims with nephrological problems. Despite the potential risk of a high mortality, in the case of appropriate and energetic medical interventions, reasonable final outcomes can be achieved.

Keywords:
Marmara earthquake, Crush syndrome, Dialysis, Outcome
1.
Weisberg LS, Allgreen RL, Genter FC, Kurnik BRC: Cause of acute tubular necrosis affects its prognosis. Arch Intern Med 1997;157:1833–1838.
2.
Better OS, Stein JH: Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 1990;322:825–829.
3.
Michaelson M: Crush injury and crush syndrome. World J Surg 1992;16:899–903.
4.
Better OS: Acute renal failure in casualties of mass disasters. Kidney Int 1993;43(suppl 41):235–236.
5.
Baba S, Taniguchi H, Nambu S, Tsuboi S, Ishihara K, Osato T: The great Hanshin earthquake. Lancet 1996;347:307–309.
6.
T.C. Basbakanlik Kriz Yönetim Merkezi. Depremler 1999. Basbakanlik Basimevi, Ankara 2000, pp 3–15. (Crisis Center of the Turkish Prime Ministry: Earthquakes 1999. Ankara, Press of Prime Ministry, 2000, pp 3–15.)
7.
Vanholder R, Sever MS, De Smet M, Erek E, Lameire N: Intervention of the Renal Disaster Relief Task Force in the 1999 Marmara, Turkey, earthquake. Kidney Int 2001;59:783–791.
8.
Sever MS, Erek E, Vanholder R, Akoglu E, Yavuz M, Ergin H, Tekçe M, Korular D, Tulbek MY, Keven K, van Vlem B, Lameire N: The Marmara earthquake – epidemiological analysis of the victims with nephrological problems. Kidney Int 2001:60:1114–1123.
9.
Slater MS, Mullins RJ: Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: A review. J Am Coll Surg 1998;186:693–716.
10.
Better OS: Traumatic rhabdomyolysis (‘crush syndrome’) – updated 1989. Isr J Med Sci 1989;25:69–72.
11.
Vanholder R, Sever MS, Erek E, Lameire N: Acute renal failure related to the crush syndrome: Towards an era of seismo-nephrology? Nephrol Dial Transplant 2000;15:1517–1521.
12.
Collins AJ, Burzstein S: Renal failure in disasters. Crit Care Clin 1991;7:421–435.
13.
Knochel JP: Rhabdomyolysis and acute renal failure; in Glassock RJ (ed): Current Therapy in Nephrology and Hypertension, ed 4. St. Louis, Mosby, 1998, pp 262–265.
14.
Richards NT, Tattersall J, MacCann M, Samson A, Mathias T, Johnson A: Dialysis for acute renal failure due to crush injuries after the Armenian earthquake. BMJ 1989;298:443–445.
15.
Solez K, Bihari D, Collins AJ, Eknoyan G, Eliahou H, Fedorov VD, Kjellstrand C, Lameire N, Letteri J, Nissenson AR et al: International dialysis aid in earthquakes and other disasters. Kidney Int 1993;44:479–483.
16.
Forni LG, Hilton PJ: Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med 1997;336:1303–1309.
17.
Vanholder R, Sever MS, Erek E, Lameire N: Rhabdomyolysis. J Am Soc Nephrol 2000;11:1553–1561.
18.
Whittaker R, Fareed D, Green P, Barry P, Borge A, Fletes-Barrios R: Earthquake disaster in Nicaragua. J Trauma 1974;14:37–43.
19.
Obialo CI, Okonofura EC, Nzerue M, Tayade AS, Riley LJ: Role of hypoalbuminemia and hypercholesterolemia as co-predictors of mortality in acute renal failure. Kidney Int 1999;56:1058–1063.
20.
Barton IK, Hilton PJ, Taub NA, Warburton FG, Swan AV, Dwight J, Mason JC: Acute renal failure treated by haemofiltration: Factors affecting outcome. Q J Med 1993;86:81–90.
21.
Ron D, Taitelman U, Michaelson M, Bar-Joseph G, Burzstein S, Better OS: Prevention of acute renal failure in traumatic rhabdomyolysis. Arch Intern Med 1984;44:277–280.
22.
Zager RA: Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 1996;49:314–326.
23.
Shimazu T, Yoshioka T, Nakata Y, Ishikawa K, Mizushima Y, Morimoto F, Kishi M, Takaoka M, Tanaka H, Iwai A, Hiraide A: Fluid resuscitation and systemic complications in crush syndrome: 14 Hanshin-Awaji earthquake patients. J Trauma 1997;42:641–646.
24.
Oda J, Tanaka H, Yoshioka T, Iwai A, Yamamura H, Ishikawa K, Matsuoka T, Kuwagata Y, Hiraide A, Shimazu T, Sugimoto H: Analysis of 372 patients with crush syndrome caused by the Hanshin-Awaji earthquake. J Trauma 1997;42:470–476.
25.
Better OS, Rubinstein I: Management of shock and acute renal failure in casualties suffering from the crush syndrome. Ren Fail 1997;19:647–653.
26.
Better OS, Rubinstein I, Winaver JM, Knochel JP: Mannitol therapy revisited (1940–1997). Kidney Int 1997;52:886–894.
27.
Woodrow G, Brownjohn AM, Turney JH: The clinical and biochemical features of acute renal failure due to rhabdomyolysis. Ren Fail 1995;17:467–474.
28.
Atef MR, Nadjatfi I, Boroumand B, Rastegar A: Acute renal failure in earthquake victims in Iran: Epidemiology and management. Q J Med 1994;87:35–40.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.